Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001493152-21-015562
Filing Date
2021-06-29
Accepted
2021-06-29 16:38:09
Documents
3
Period of Report
2021-06-29

Document Format Files

Seq Description Document Type Size
1 formdef14a.htm DEF 14A 549678
2 logo_001.jpg GRAPHIC 4307
3 proxyfornt_001.jpg GRAPHIC 610013
  Complete submission text file 0001493152-21-015562.txt   1396695
Mailing Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129
Business Address 9137 RIDGELINE BOULEVARD SUITE 135 HIGHLANDS RANCH CO 80129 (866)908-4867
Vivos Therapeutics, Inc. (Filer) CIK: 0001716166 (see all company filings)

EIN.: 813224056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39796 | Film No.: 211058663
SIC: 3841 Surgical & Medical Instruments & Apparatus